Farxiga vs Ozempic: Pros, Cons & Differences Explained

Farxiga and Ozempic are prescribed for type 2 diabetes, and both may support weight loss, but neither is FDA-approved for it. 

The differences come down to how each drug works, what it's best at, and which outcomes matter most to you. 

This article breaks down the key differences side by side, covers which option fits which goal, and explains when a provider might recommend using them together.

What Is Farxiga?

Farxiga is the brand name for dapagliflozin, an oral tablet used to treat type 2 diabetes, heart failure, and chronic kidney disease. It belongs to the Sodium-Glucose Co-Transporter 2 (SGLT2) inhibitor drug class.

SGLT2 is a protein in the kidneys that helps reabsorb glucose back into the bloodstream. By blocking this protein, Farxiga helps the body remove excess sugar through the urine.

How Does It Work?

Farxiga blocks the SGLT2 protein in the kidneys, which normally reabsorbs glucose back into the bloodstream. 

When that protein is blocked, excess glucose is excreted in the urine. Blood sugar drops as a result, without the need for insulin.

What Is Ozempic?

Ozempic, which is the brand name for semaglutide, is a once-weekly injectable medication approved for the treatment of type 2 diabetes. 

Semaglutide is the active ingredient used in Ozempic. And it’s also used in Wegovy, which is approved specifically for weight management. 

For context on how semaglutide compares to other GLP-1 options, the liraglutide vs semaglutide comparison covers the key distinctions.

How Does It Work?

Ozempic is a GLP-1 receptor agonist that activates receptors in the gut and brain. This slows the rate at which food leaves your stomach, reduces glucagon (a hormone that raises blood sugar), and signals the brain to reduce appetite. 

The result is lower blood sugar and, for most people, meaningful weight loss. 

For a deeper look at how semaglutide, a GLP-1 receptor agonist, compares to tirzepatide, a dual GLP-1 and GIP receptor agonist, read our comparison guide on semaglutide vs. tirzepatide.

Key Differences: Farxiga vs Ozempic

At a glance, these drugs treat overlapping conditions but work through entirely different mechanisms and carry different strengths.

‍

1. Drug Class and Mechanism

Farxiga

Farxiga works through the kidneys. It doesn't depend on insulin and doesn't stimulate the pancreas. 

That makes it effective even in patients with reduced insulin production, and it carries a low risk of hypoglycemia when used alone.

Ozempic

Ozempic works through the gut and brain. It mimics a hormone the body naturally produces after eating. 

Because it directly affects appetite and digestion, its metabolic effects extend beyond blood sugar, reaching weight, hunger, and eating behavior.

2. Weight Loss Outcomes

Farxiga

In clinical trials, dapagliflozin has been associated with an average weight loss of about 2-3 kg over roughly 24 weeks. The effect is considered modest and is not the primary reason for prescribing the medication.

The weight change is largely attributable to urinary glucose excretion and mild fluid loss, rather than to a direct appetite-suppressing or fat-targeting mechanism.

Ozempic

Ozempic, compared to Farxiga, may produce more weight reduction. In higher-dose weight loss studies, some patients lost up to 15% of their body weight. The weight loss mechanism is central to how the drug works, not a side effect.

3. Blood Sugar Control (A1C Reduction)

Farxiga

Farxiga typically reduces A1C by 0.5% to 0.7%. The effect is consistent but less pronounced than some injectable options. It works well as an add-on to metformin or insulin.

Ozempic

Ozempic may reduce HbA1C by 0.6% to 1.6%, depending on dose, background therapy, and baseline levels. Semaglutide has consistently shown strong A1C reduction alongside meaningful weight loss.

4. Heart and Kidney Protection

Farxiga

The DAPA-HF and DAPA-CKD trials showed significant reductions in heart failure hospitalizations and slowed kidney disease progression, including in patients without diabetes. 

Farxiga is now approved by the USA and the EU for adult symptomatic heart failure as standalone indications.

Ozempic

The SUSTAIN-6 trials showed that semaglutide may reduce cardiovascular events like heart attack and stroke in high-risk patients with T2D. 

Its kidney benefits are secondary to its cardiovascular profile. Providers with patients who have both conditions often weigh both drugs together.

5. Dosing and Administration

Farxiga

Farxiga is a once-daily oral tablet, typically 10mg. Because it’s taken by mouth, it may be easier to initiate and maintain for patients who prefer to avoid injevctable therapies.

Ozempic

Ozempic is a once-weekly subcutaneous injection into the fat layer of the skin, the abdomen, thigh, or upper arm. It's self-administered at home and requires a short adjustment period.

The subcutaneous delivery method is well-tolerated by most patients. 

For guidance on injection technique, the how to Inject Semaglutide guide walks through the process step by step.

6. Cost and Insurance Access

Farxiga

Brand-name Farxiga may cost between $500 to $600 per month without insurance. Generic dapagliflozin is now available and may significantly reduce out-of-pocket costs. 

Ozempic

Brand-name Ozempic costs may range between $900 to $1,600 per month without insurance. Coverage is inconsistent, particularly when prescribed off-label for weight loss rather than diabetes. 

Personalized GLP-1 injections containing semaglutide are available through licensed telehealth providers and start at $175 per month. 

For a direct comparison of weight management and blood sugar control across the main GLP-1 options, our detailed guide on Wegovy, Ozempic, and Mounjaro breaks it down clearly. 

Can You Take Farxiga and Ozempic Together?

Yes. The combination is more common than many people realize.

Using Ozempic with Farxiga is an established strategy for patients with type 2 diabetes, especially those with cardiovascular or kidney risk. 

Although the two drugs work through different mechanisms, they complement rather than duplicate each other.

The combination may improve A1C control, support additional weight loss, and provide layered protection for the heart and kidneys. Ongoing monitoring is important, particularly for blood pressure and kidney function.

To understand how semaglutide interacts with the body over time, what semaglutide does to your body is a useful read. 

How to Choose the Right One for Your Goals

Step 1: Identify Your Primary Condition

If your primary diagnosis is heart failure or chronic kidney disease, Farxiga has specific approvals and FDA supporting evidence for both.

If your main concern is type 2 diabetes with weight gain, Ozempic’s effects on blood sugar and appetite may make it a more suitable option.

For context on how different injections compare for weight-focused goals, what is the best injection for weight loss?

Step 2: Factor In Your Tolerance for Injections

Farxiga is a daily oral pill. Ozempic is a weekly subcutaneous injection. If needles are a genuine barrier, Farxiga offers meaningful blood sugar and heart protection without requiring injection. 

If you're open to self-injection, Ozempic's weight loss outcomes may justify the small adjustment period.

Step 3: Consider Cost and Access

Brand-name pricing for both drugs is high. If insurance won't cover Ozempic and weight loss is your goal, a licensed telehealth provider can prescribe personalized GLP-1 injections containing semaglutide at a fraction of the cost. 

IvyRx offers this starting at $175 per month, with medical evaluation, dosing guidance, and provider support included—no insurance required.

Start Your Weight Loss Journey With IvyRx Today

If Ozempic’s cost or insurance barriers are limiting your options, you may not need to step away from semaglutide altogether.

IvyRx offers personalized GLP-1 injections through a fully online process. A licensed provider reviews your medical history and determines whether treatment is appropriate. If approved, a regulated pharmacy dispenses your prescription, and your medication ships directly to your door for at-home use.

Programs start at $175 per month.

‍